ANNE ESLAVA: Open Payments
NPI 1528631322 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 72 payments from 10 companies in 2025. Trend: 2023 $276 · 2024 $2,152 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $239 |
| Teva Pharmaceuticals USA, Inc. | 14 | $200 |
| Otsuka America Pharmaceutical, Inc. | 9 | $187 |
| Neurocrine BioSciences, Inc. | 7 | $184 |
| ABBVIE INC. | 17 | $138 |
| AstraZeneca Pharmaceuticals LP | 1 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Lundbeck LLC | 4 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
Products named: ARISTADA, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, UZEDY, ABILIFY MAINTENA, AUSTEDO XR, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
